当前位置: 首页 >> 检索结果
41. The Usefulness of the Rapid Shallow Breathing Index in Predicting Successful Extubation: A Systematic Review and Meta-analysis.
作者: Vatsal Trivedi.;Dipayan Chaudhuri.;Rehman Jinah.;Joshua Piticaru.;Arnav Agarwal.;Kuan Liu.;Eric McArthur.;Michael C Sklar.;Jan O Friedrich.;Bram Rochwerg.;Karen E A Burns.
来源: Chest. 2022年161卷1期97-111页
Clinicians use several measures to ascertain whether individual patients will tolerate liberation from mechanical ventilation, including the rapid shallow breathing index (RSBI).
42. Safety of Thoracentesis and Tube Thoracostomy in Patients With Uncorrected Coagulopathy: A Systematic Review and Meta-analysis.
作者: Clare Fong.;Colin Wei Chang Tan.;Drusilla Kai Yan Tan.;Kay Choong See.
来源: Chest. 2021年160卷5期1875-1889页
Thoracentesis and tube thoracostomy are common procedures with bleeding risks, but existing guidelines may be overly conservative. We reviewed the evidence on the safety of thoracentesis and tube thoracostomy in patients with uncorrected coagulopathy.
43. Breathlessness Predicts Survival in Patients With Malignant Pleural Effusions: Meta-analysis of Individual Patient Data From Five Randomized Controlled Trials.
作者: Eleanor K Mishra.;Sanjeevan Muruganandan.;Allan Clark.;Rahul Bhatnagar.;Nick Maskell.;Y C Gary Lee.;Najib M Rahman.
来源: Chest. 2021年160卷1期351-357页
Patients with malignant pleural effusions (MPEs) experience breathlessness and poor survival. Breathlessness is associated with poor survival in other conditions.
44. Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
作者: Daisuke Hasegawa.;Ryota Sato.;Narut Prasitlumkum.;Kazuki Nishida.;Kunihiko Takahashi.;Tomoaki Yatabe.;Osamu Nishida.
来源: Chest. 2021年159卷6期2289-2300页
Historically, β-blockers have been considered to be relatively contraindicated for septic shock because they may cause cardiac suppression. On the other hand, there is an increasing interest in the use of β-blockers for treating patients with sepsis with persistent tachycardia despite initial resuscitation.
45. Safety and Efficacy of Dexmedetomidine in Acutely Ill Adults Requiring Noninvasive Ventilation: A Systematic Review and Meta-analysis of Randomized Trials.
作者: Kimberley Lewis.;Joshua Piticaru.;Dipayan Chaudhuri.;John Basmaji.;Eddy Fan.;Morten Hylander Møller.;John W Devlin.;Waleed Alhazzani.
来源: Chest. 2021年159卷6期2274-2288页
Although clinical studies have evaluated dexmedetomidine as a strategy to improve noninvasive ventilation (NIV) comfort and tolerance in patients with acute respiratory failure (ARF), their results have not been summarized.
46. Carbapenem Antibiotics for the Empiric Treatment of Nosocomial Pneumonia: A Systematic Review and Meta-analysis.
作者: Mackenzie Howatt.;Michael Klompas.;Andre C Kalil.;Mark L Metersky.;John Muscedere.
来源: Chest. 2021年159卷3期1041-1054页
Previous meta-analyses suggested that treating hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), with empiric carbapenems was associated with lower mortality rates but higher rates of clinical failure for pseudomonal pneumonia. This study was an updated meta-analysis with sensitivity analyses and meta-regression to better understand the impact of carbapenem use in HAP/VAP.
47. Impact of Right Ventricular Dysfunction on Short-term and Long-term Mortality in Sepsis: A Meta-analysis of 1,373 Patients.
作者: Saraschandra Vallabhajosyula.;Aditi Shankar.;Rahul Vojjini.;Wisit Cheungpasitporn.;Pranathi R Sundaragiri.;Hilary M DuBrock.;Hiroshi Sekiguchi.;Robert P Frantz.;Hector R Cajigas.;Garvan C Kane.;Jae K Oh.
来源: Chest. 2021年159卷6期2254-2263页
Right ventricular (RV) dysfunction in sepsis and septic shock has been infrequently studied and has uncertain prognostic significance.
48. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.
作者: David Jiménez.;Aldara García-Sanchez.;Parth Rali.;Alfonso Muriel.;Behnood Bikdeli.;Pedro Ruiz-Artacho.;Raphael Le Mao.;Carmen Rodríguez.;Beverley J Hunt.;Manuel Monreal.
来源: Chest. 2021年159卷3期1182-1196页
Individual studies have reported widely variable rates for VTE and bleeding among hospitalized patients with coronavirus disease 2019 (COVID-19).
49. Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis.
作者: Edison J Cano.;Xavier Fonseca Fuentes.;Cristina Corsini Campioli.;John C O'Horo.;Omar Abu Saleh.;Yewande Odeyemi.;Hemang Yadav.;Zelalem Temesgen.
来源: Chest. 2021年159卷3期1019-1040页
Since its appearance in late 2019, infections caused by severe acute respiratory syndrome coronavirus 2 have created unprecedented challenges for health systems worldwide. Multiple therapeutic options have been explored, including corticosteroids. Preliminary results of corticosteroids in coronavirus disease 2019 (COVID-19) are encouraging; however, the role of corticosteroids remains controversial.
50. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.
The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented burden on the delivery of intensive care services worldwide.
51. Acetazolamide for OSA and Central Sleep Apnea: A Comprehensive Systematic Review and Meta-Analysis.
作者: Christopher N Schmickl.;Shane A Landry.;Jeremy E Orr.;Kazuo Chin.;Kimihiko Murase.;Johan Verbraecken.;Shahrokh Javaheri.;Bradley A Edwards.;Robert L Owens.;Atul Malhotra.
来源: Chest. 2020年158卷6期2632-2645页
Therapy options for OSA and central sleep apnea (CSA) are limited, thus many patients remain untreated. Clinically, acetazolamide is sometimes used for CSA; however, given overlapping pathophysiologic properties of OSA and CSA, we hypothesized that acetazolamide is equally effective for both types. Prior reviews focused on specific subtypes of sleep apnea, study designs, and languages, thus including few studies (typically ≤3) limiting insights.
52. Higher vs Lower Oxygenation Strategies in Acutely Ill Adults: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.
作者: Marija Barbateskovic.;Olav L Schjørring.;Sara Russo Krauss.;Christian S Meyhoff.;Janus C Jakobsen.;Bodil S Rasmussen.;Anders Perner.;Jørn Wetterslev.
来源: Chest. 2021年159卷1期154-173页
Liberal oxygen supplementation is often used in acute illness but has, in some studies, been associated with harm.
53. Standardized Management for Hypoxemic Respiratory Failure and ARDS: Systematic Review and Meta-analysis.
作者: Ken Kuljit S Parhar.;Henry T Stelfox.;Kirsten M Fiest.;Gordon D Rubenfeld.;Danny J Zuege.;Gwen Knight.;Helen Lee Robertson.;Andrea Soo.;Christopher J Doig.;Daniel J Niven.
来源: Chest. 2020年158卷6期2358-2369页
Treatment of hypoxemic respiratory failure (HRF) and ARDS is complex. Standardized management of HRF and ARDS may improve adherence to evidence-informed practice and improve outcomes.
54. High-Flow Nasal Cannula in the Immediate Postoperative Period: A Systematic Review and Meta-analysis.
作者: Dipayan Chaudhuri.;David Granton.;Dominic Xiang Wang.;Karen E A Burns.;Yigal Helviz.;Sharon Einav.;Vatsal Trivedi.;Tommaso Mauri.;Jean-Damien Ricard.;Jordi Mancebo.;Jean-Pierre Frat.;Sameer Jog.;Gonzalo Hernandez.;Salvatore M Maggiore.;Lawrence Mbuagbaw.;Carol L Hodgson.;Samir Jaber.;Ewan C Goligher.;Laurent Brochard.;Bram Rochwerg.
来源: Chest. 2020年158卷5期1934-1946页
Studies have demonstrated that high-flow nasal cannula (HFNC) prevents intubation in acute hypoxic respiratory failure when compared with conventional oxygen therapy (COT). However, the data examining routine HFNC use in the immediate postoperative period are less clear.
55. Chest CT Imaging Signature of Coronavirus Disease 2019 Infection: In Pursuit of the Scientific Evidence.
作者: Hugo J A Adams.;Thomas C Kwee.;Derya Yakar.;Michael D Hope.;Robert M Kwee.
来源: Chest. 2020年158卷5期1885-1895页
Chest CT may be used for the diagnosis of coronavirus disease 2019 (COVID-19), but clear scientific evidence is lacking. Therefore, we systematically reviewed and meta-analyzed the chest CT imaging signature of COVID-19.
56. Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.
作者: Nirupama Putcha.;Ashraf Fawzy.;Elizabeth C Matsui.;Mark C Liu.;Russ P Bowler.;Prescott G Woodruff.;Wanda K O'Neal.;Alejandro P Comellas.;MeiLan K Han.;Mark T Dransfield.;J Michael Wells.;Njira Lugogo.;Li Gao.;C Conover Talbot.;Eric A Hoffman.;Christopher B Cooper.;Laura M Paulin.;Richard E Kanner.;Gerard Criner.;Victor E Ortega.;R Graham Barr.;Jerry A Krishnan.;Fernando J Martinez.;M Bradley Drummond.;Robert A Wise.;Gregory B Diette.;Craig P Hersh.;Nadia N Hansel.
来源: Chest. 2020年158卷6期2333-2345页
Little is known about the concordance of atopy with asthma COPD overlap. Among individuals with COPD, a better understanding of the phenotypes characterized by asthma overlap and atopy is needed to better target therapies.
57. Sensitivity and Safety of Electromagnetic Navigation Bronchoscopy for Lung Cancer Diagnosis: Systematic Review and Meta-analysis.
作者: Erik E Folch.;Gonzalo Labarca.;Daniel Ospina-Delgado.;Fayez Kheir.;Adnan Majid.;Sandeep J Khandhar.;Hiren J Mehta.;Michael A Jantz.;Sebastian Fernandez-Bussy.
来源: Chest. 2020年158卷4期1753-1769页
Bronchoscopy is a useful tool for the diagnosis of lesions near central airways; however, the diagnostic accuracy of these procedures for peripheral pulmonary lesions (PPLs) is a matter of ongoing debate. In this setting, electromagnetic navigation bronchoscopy (ENB) is a technique used to navigate and obtain samples from these lesions. This systematic review and meta-analysis aims to explore the sensitivity of ENB in patients with PPLs suspected of lung cancer.
58. Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.
作者: Fernando Sergio Leitao Filho.;Andre Mattman.;Robert Schellenberg.;Gerard J Criner.;Prescott Woodruff.;Stephen C Lazarus.;Richard K Albert.;John Connett.;Meilan K Han.;Steven E Gay.;Fernando J Martinez.;Anne L Fuhlbrigge.;James K Stoller.;Neil R MacIntyre.;Richard Casaburi.;Philip Diaz.;Ralph J Panos.;J Allen Cooper.;William C Bailey.;David C LaFon.;Frank C Sciurba.;Richard E Kanner.;Roger D Yusen.;David H Au.;Kenneth C Pike.;Vincent S Fan.;Janice M Leung.;Shu-Fan Paul Man.;Shawn D Aaron.;Robert M Reed.;Don D Sin.
来源: Chest. 2020年158卷4期1420-1430页
Hypogammaglobulinemia (serum IgG levels < 7.0 g/L) has been associated with increased risk of COPD exacerbations but has not yet been shown to predict hospitalizations.
59. Efficacy of CPAP for Improvements in Sleepiness, Cognition, Mood, and Quality of Life in Elderly Patients With OSA: Systematic Review and Meta-analysis of Randomized Controlled Trials.
作者: Gonzalo Labarca.;Daniela Saavedra.;Jorge Dreyse.;Jorge Jorquera.;Ferran Barbe.
来源: Chest. 2020年158卷2期751-764页
OSA is found commonly in the elderly population (≥65 years old), and CPAP improves sleepiness and health-related quality of life (HRQoL) in the middle-aged population; however, data about its efficacy in elderly patients are unclear. The purpose of this study was to evaluate the efficacy of CPAP for sleepiness, HRQoL, mood, and cognition in elderly patients with OSA.
60. Change in V˙O2peak in Response to Aerobic Exercise Training and the Relationship With Exercise Prescription in People With COPD: A Systematic Review and Meta-analysis.
作者: Thomas J C Ward.;Charles D Plumptre.;Thomas E Dolmage.;Amy V Jones.;Ruth Trethewey.;Pip Divall.;Sally J Singh.;Martin R Lindley.;Michael C Steiner.;Rachael A Evans.
来源: Chest. 2020年158卷1期131-144页
Despite the wide-ranging benefits of pulmonary rehabilitation, conflicting results remain regarding whether people with COPD can improve their peak oxygen uptake (V˙O2peak) with aerobic training.
|